Aptose Biosciences (APTO) Stock Soars 31.50%: A Penny Stock on the Rise
Aptose Biosciences (APTO) is a clinical-stage precision oncology company dedicated to addressing unmet needs in hematologic malignancies. The…
CEL-SCI Corporation: Leading the Future of Cancer Immunotherapy with Multikine®
CEL-SCI Corporation is a biotechnology leader committed to revolutionizing cancer treatment through innovative immunotherapy approaches. Founded in 1983…
Ginkgo Bioworks (DNA): A Leader in Synthetic Biology Driving Innovation in 2024
Founded in 2008 by a team of visionary scientists from MIT, Ginkgo Bioworks Holdings Inc. (DNA) has emerged…
Hyperfine (HYPR)’s Swoop® Portable MRI: Transforming Emergency Neurological Care
Hyperfine Inc. (HYPR) is at the forefront of transforming brain imaging with its groundbreaking Swoop® Portable MRI System,…
Quantum-Si (QSI) Stock Soars: QSI Can Be the Future of Protein Sequencing
Quantum-Si Incorporated (QSI) is a revolutionary life sciences company that is transforming the field of proteomics through cutting-edge…
Lan Su, COO of Lakeside Holding, Shares His Vision and Strategies for Charting New Horizons
Biotech Health X recently had the opportunity to sit down with Lan Su, the newly appointed Chief Operating…
Voyager Therapeutics (VYGR) Reports $24.6M in Q3 2024 Collaboration Revenues
Voyager Therapeutics Inc. (VYGR) is a pioneering biotechnology company at the forefront of developing innovative gene therapies for…
aTyr Pharma (ATYR) Raises $19.4 Million to Support Drug Development and Clinical Trials
aTyr Pharma Inc. (ATYR) is a pioneering clinical-stage biopharmaceutical company dedicated to developing novel, first-in-class therapies for patients…
Aquestive Therapeutics (AQST) Reports Strong Q3 2024 Financial Results with 4% Revenue Growth
Aquestive Therapeutics Inc. (AQST) is a cutting-edge pharmaceutical company dedicated to transforming the way medicines are delivered to…
The Next Big Player in Immuno-Oncology: iTeos Therapeutics (ITOS)
iTeos Therapeutics Inc. (ITOS), a clinical-stage biopharmaceutical company, is dedicated to pioneering the discovery and development of next-generation…
Protagonist Therapeutics (PTGX)Exceeds Revenue Estimates in Q3 2024
Protagonist Therapeutics Inc. (PTGX) is an innovative clinical-stage biopharmaceutical company that specializes in the discovery and development of…
Madrigal Pharmaceuticals (MDGL): A Financial Powerhouse With $1.0 Billion Cash Position in 2024
Madrigal Pharmaceuticals Inc. (MDGL) is a pioneering biopharmaceutical company focused on developing and commercializing novel, life-changing therapies for…
Kamada (KMDA) Reports Strong Q3 2024 Financial Results with $41.7M in Revenue
Kamada Ltd. (KMDA) is a prominent global biopharmaceutical company that has established itself as a leader in the…
Gossamer Bio (GOSS) Reports Strong Q3 2024 Financial Results
Gossamer Bio Inc. (GOSS) is a prominent clinical-stage biopharmaceutical company based in San Diego, California, committed to the…
Lakeside (LSH) Partners with Huiyu Pharmaceutical to Expand Global Oncology Drug Distribution
Lakeside Holding Limited (LSH) is a dynamic U.S.-based cross-border supply chain solution provider, strategically headquartered in Itasca, Illinois.…
Sanara MedTech (SMTI) Achieves Record $21.7M Revenue in Q3 2024
Sanara MedTech Inc. (SMTI), headquartered in Fort Worth, Texas, is a leading medical technology company dedicated to developing…
Aldeyra (ALDX) Reports $15.1M Q3 2024 Loss Amid R&D Investments
Aldeyra Therapeutics Inc. (ALDX) is a clinical-stage biotechnology company that stands at the forefront of innovation in addressing…
Galectin (GALT) Reports Improved Financial Performance in Q3 2024
Galectin Therapeutics Inc. (GALT) is a pioneering biopharmaceutical company dedicated to developing innovative therapies that target galectin proteins,…